Aflibercept Injection for Proliferative Diabetic Retinopathy

PHASE2CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

February 28, 2014

Study Completion Date

November 30, 2015

Conditions
Vitreous Hemorrhage
Interventions
DRUG

Intravitreal Aflibercept Injection

One time 2.0mg aflibercept injection, following pars plana vitrectomy.

OTHER

Standard Vitrectomy

Surgical intervention

Trial Locations (1)

73104

Dean McGee Eye Institute, Oklahoma City

All Listed Sponsors
lead

University of Oklahoma

OTHER

NCT01805297 - Aflibercept Injection for Proliferative Diabetic Retinopathy | Biotech Hunter | Biotech Hunter